Analysis

Biomark Diagnostics, Inc. (BUX) Stock Analysis

Biomark Diagnostics, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to BUX.

websiteBUX/analysis/BUX

Biomark Diagnostics, Inc.

Biomark Diagnostics, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to BUX.

Stock profile

Ticker

BUX

Asset type

Stock

Market cap

$40.1M

Sector

Health Services

Industry

Medical/Nursing Services

Currency

CAD

Ticker listings

Biomark Diagnostics, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • BUX primary listing
  • BMKDF
  • A12EKB
  • 20B

Latest Biomark Diagnostics, Inc. news

BioMark Diagnostics Secures Landmark Canadian and European Patent Allowances for Early-Stage Lung Cancer Blood Test

BioMark prepares to launch its breakthrough liquid biopsy powered by a newly patented algorithm validated in over 15,000 samples across Quebec, France, and Germany.Vancouver, Br...

BioMark Diagnostics to Present Liquid Biopsy Platform at the Canadian Thoracic Society Research Forum

BioMark Comprehensive Metabolomics Assay Selected as Top Canadian Innovation for the CTS Beaver Den Innovation AwardVancouver, British Columbia--(Newsfile Corp. - April 14, 2026...

BioMark Diagnostics Announces Publication of Peer-Reviewed Validation of Machine Learning Models for Lung Cancer Detection in Frontiers i...

Advancing Superior Accuracy in Early Lung Cancer Detection Using Selective Metabolic Pathways and Data Enrichment for Enhanced Diagnostic CapabilitiesVancouver, British Columbia...

BioMark: 2025 Achievements & 2026 Vision

Celebrating A Year of Extraordinary AchievementVancouver, British Columbia--(Newsfile Corp. - December 31, 2025) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) ...

BioMark Diagnostics Announces Appointment of Mr. James Lavender to Board of Directors

Expanding U.S. market access with an experienced technology investor and AI-driven growth strategistVancouver, British Columbia--(Newsfile Corp. - December 30, 2025) - BioMark D...

Research sections

Valuation

Review valuation context for Biomark Diagnostics, Inc..

Future growth

Review future growth context for Biomark Diagnostics, Inc..

Past performance

Review past performance context for Biomark Diagnostics, Inc..

Financial health

Review financial health context for Biomark Diagnostics, Inc..

Dividend

Review dividend context for Biomark Diagnostics, Inc..

Management

Review management context for Biomark Diagnostics, Inc..

Ownership

Review ownership context for Biomark Diagnostics, Inc..

Other information

Review other information context for Biomark Diagnostics, Inc..

Community

Review community context for Biomark Diagnostics, Inc..